Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

A Phase 1/2 Study of NS-018, an Oral JAK2 Inhibitor, in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (pPV MF), or Post-Essential Thrombocythemia Myelofibrosis (pET MF)

Srdan Verstovsek, MD, Moshe Talpaz, MD, Ellen Ritchie, MD, Martha Wadleigh, MD, Olatoyosi Odenike, MD, Catriona Jamieson, MD PhD, Brady Stein, MD, Tomonori Uno, PhD, Ruben A. Mesa

Blood (2015) 126 (23): 2800.

https://doi.org/10.1182/blood.V126.23.2800.2800

Published: 2015

Journal Articles

Incidence and Differential Diagnosis of Human Herpes Virus-6 Associated Encephalitis/Myelitis in Allogeneic Stem Cell Transplantation That Mimics Calcineurin Inhibitor-Induced Pain Syndrome

Goichi Yoshimoto, MDPhD, Toshihiro Miyamoto, MD PhD, Koji Kato, MD PhD, Yasuo Mori, MDPhD, Kenjiro Kamezaki, MDPhD, Katsuto Takenaka, MDPhD, Hiromi Iwasaki, MD PhD, Koichi Akashi, MD PhD

Blood (2015) 126 (23): 1912.

https://doi.org/10.1182/blood.V126.23.1912.1912

Published: 2015

Journal Articles

Catheter Related Thrombosis in Breast Cancer Patients: Risk Factors and Prognostic Implications

Gabriela N. Cesarman-Maus, MD, PhD, Patricia Cornejo, MD, Luis Oñate, MD, Rosario Villa, ChemD, Yolanda Miranda, MBA, Jose Luis Aguilar, MD, Marianela Siñani, MD, Patricia Volkow, MD

Blood (2012) 120 (21): 1139.

https://doi.org/10.1182/blood.V120.21.1139.1139

Published: 2012

Journal Articles

Baseline Peripheral Neuropathy Does Not Impact the Efficacy and Tolerability of the Novel Proteasome Inhibitor Carfilzomib (CFZ): Results of a Subset Analysis of a Phase 2 Trial In Patients with Relapsed and Refractory Multiple Myeloma (R/R MM)

Blood (2010) 116 (21): 3031.

https://doi.org/10.1182/blood.V116.21.3031.3031

Published: 2010

Journal Articles

Systematic Review of the Surgical Treatment of Moderate to Severe Post-Thrombotic Syndrome

Rachel T Bond, Jacqueline M. Cohen, Susan R. Kahn, MD, MSc

Blood (2010) 116 (21): 3170.

https://doi.org/10.1182/blood.V116.21.3170.3170

Published: 2010

Journal Articles

Pharmacogenomic (PGx) Analysis of Bortezomib-Associated Peripheral Neuropathy in the Phase 3 VISTA Trial of Bortezomib Plus Melphalan–Prednisone Versus Melphalan–Prednisone in Multiple Myeloma.

Deborah S Ricci, Reyna Favis, Yu Sun, Helgi van de Velde, Erin Broderick, Michael Meyers, Jean-Luc Harousseau, Hervé Avet-Loiseau, Paul G Richardson, Jesús F San Miguel

Blood (2009) 114 (22): 3875.

https://doi.org/10.1182/blood.V114.22.3875.3875

Published: 2009

Journal Articles

POEMS Syndrome Objective Clinical Response of Polyneuropathy to Lenolidomide.

Reetika Grewal, MD, Said Beydoun, MD, Ann Mohrbacher, MD

Blood (2009) 114 (22): 4964.

https://doi.org/10.1182/blood.V114.22.4964.4964

Published: 2009

Journal Articles

Carfilzomib (CFZ), a Novel Proteasome Inhibitor for Relapsed or Refractory Multiple Myeloma, Is Associated with Minimal Peripheral Neuropathic Effects.

Ravi Vij, MD, Luhua Wang, MD, Robert Z Orlowski, M.D., Ph.D., A. Keith Stewart, MD, Sundar Jagannath, MD, Sagar Lonial, MD, Suzanne Trudel, MD, Andrzej J Jakubowiak, MD, PhD, Andrew Belch, MD, Melissa Alsina, MD, Nizar J Bahlis, MD, Mai H. Le, MD, Scott Cruickshank, BA, MS, Mark K Bennett, PhD, Susan Molineaux, PhD, Michael Kauffman, MD, PhD, David Siegel, MD, The Multiple Myeloma Research Consortium (MMRC)

Blood (2009) 114 (22): 430.

https://doi.org/10.1182/blood.V114.22.430.430

Published: 2009

Journal Articles

Pegylated Liposomal Doxorubicin in Primary Cutaneous Lymphomas: Efficacy, Safety, and Low Rate of Palmar-Plantar Erythrodysesthesia

Stefano Pulini, Serena Rupoli, Nicola Pimpinelli, Annalisa Natale, Gaia Goteri, Anna Rita Scortechini, Paola Picardi, Simonetta Mulattieri, Pietro Leoni, Giuseppe Fioritoni

Blood (2008) 112 (11): 4932.

https://doi.org/10.1182/blood.V112.11.4932.4932

Published: 2008

NARROW

A Phase 1/2 Study of NS-018, an Oral JAK2 Inhibitor, in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (pPV MF), or Post-Essential Thrombocythemia Myelofibrosis (pET MF)

Incidence and Differential Diagnosis of Human Herpes Virus-6 Associated Encephalitis/Myelitis in Allogeneic Stem Cell Transplantation That Mimics Calcineurin Inhibitor-Induced Pain Syndrome

Catheter Related Thrombosis in Breast Cancer Patients: Risk Factors and Prognostic Implications

Baseline Peripheral Neuropathy Does Not Impact the Efficacy and Tolerability of the Novel Proteasome Inhibitor Carfilzomib (CFZ): Results of a Subset Analysis of a Phase 2 Trial In Patients with Relapsed and Refractory Multiple Myeloma (R/R MM)

Systematic Review of the Surgical Treatment of Moderate to Severe Post-Thrombotic Syndrome

Pharmacogenomic (PGx) Analysis of Bortezomib-Associated Peripheral Neuropathy in the Phase 3 VISTA Trial of Bortezomib Plus Melphalan–Prednisone Versus Melphalan–Prednisone in Multiple Myeloma.

POEMS Syndrome Objective Clinical Response of Polyneuropathy to Lenolidomide.

Carfilzomib (CFZ), a Novel Proteasome Inhibitor for Relapsed or Refractory Multiple Myeloma, Is Associated with Minimal Peripheral Neuropathic Effects.

Pegylated Liposomal Doxorubicin in Primary Cutaneous Lymphomas: Efficacy, Safety, and Low Rate of Palmar-Plantar Erythrodysesthesia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only